Found: 3
Select item for more details and to access through your institution.
Control of acute myeloid leukemia by a trifunctional NKp46-CD16a-NK cell engager targeting CD123.
- Published in:
- Nature Biotechnology, 2023, v. 41, n. 9, p. 1296, doi. 10.1038/s41587-022-01626-2
- By:
- Publication type:
- Article
Cancer gene therapy mediated by CTS1, a p53 derivative: Advantage over wild-type p53 in growth inhibition of human tumors overexpressing MDM2.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 5, p. 789, doi. 10.1038/sj.cgt.7700163
- By:
- Publication type:
- Article
Developing a mechanistic translational PK/PD model for a trifunctional NK cell engager to predict the first‐in‐human dose for acute myeloid leukemia.
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 1, p. 1, doi. 10.1111/cts.13689
- By:
- Publication type:
- Article